Intranasal delivery of human β-amyloid peptide in rats: Effective brain targeting

Cellular and Molecular Neurobiology

Volumn 30, Issue 3, 2010, Pages 405-413

  Sipos, Eszter ^a   Kurunczi, Anita ^b   Fehér, András ^a   Penke, Zsuzsa ^a   Fülöp, Lívia ^a   Kasza, Ágnes ^a   Horváth, János ^a   Horvát, Sándor ^a,b   Veszelka, Szilvia ^b   Balogh, Gábor ^b   Kürti, Levente ^a   Eros, István ^a   Szabó Révész, Piroska ^a   Párducz, Árpád ^b   Penke, Botond ^a,b   Deli, Mária A ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Amyloid; Alzheimer's disease; Behavior; Nasal formulation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TRANEXAMIC ACID;

AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; LONG TERM MEMORY; MALE; MAZE TEST; NONHUMAN; OLFACTORY BULB; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SPATIAL MEMORY;

ADMINISTRATION, INTRANASAL; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; AXONAL TRANSPORT; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MEMORY DISORDERS; OLFACTORY BULB; PEPTIDE FRAGMENTS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; STAINING AND LABELING;

RATTUS;

EID: 77952091921     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9463-6     Document Type: Article

References (33)

1. WA Banks SM Robinson S Verma JE Morley 2003 Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease Neuroscience 121 487 492 10.1016/S0306-4522(03)00474-3 1:CAS:528:DC%2BD3sXns1KksLc%3D 14522007 (Pubitemid 37176936)
2. MA Chacon MI Barria C Soto NC Inestrosa 2004 Beta-sheet breaker peptide prevents abeta-induced spatial memory impairments with partial reduction of amyloid deposits Mol Psychiatr 9 953 961 10.1038/sj.mp.4001516 1:CAS:528:DC%2BD2cXnvVKmsLw%3D (Pubitemid 39381959)
3. PM Clifford S Zarrabi G Siu KJ Kinsler MC Kosciuk V Venkataraman MR D'Andrea S Dinsmore RG Nagele 2007 Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons Brain Res 1142 223 236 10.1016/j.brainres.2007.01.070 1:CAS:528:DC%2BD2sXjtFGksr0%3D 17306234 (Pubitemid 46413194)
4. MA Deli 2009 Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery Biochem Biophys Acta 1788 892 910 10.1016/j.bbamem.2008.09.016 1:CAS:528:DC%2BD1MXktFahurk%3D 18983815
5. Dodart JC, May P (2005) Overview on rodent models of Alzheimer's disease. Curr Protoc Neurosci, Chapter 9, Unit 9.22
6. MJ During L Cao DS Zuzga JS Francis HL Fitzsimons X Jiao RJ Bland M Klugmann WA Banks DJ Drucker CN Haile 2003 Glucagon-like peptide-1 receptor is involved in learning and neuroprotection Nat Med 9 1173 1179 10.1038/nm919 1:CAS:528:DC%2BD3sXmvVWnsrc%3D 12925848 (Pubitemid 37173702)
7. C Duyckaerts MC Potier B Delatour 2008 Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathol 115 5 38 10.1007/s00401-007-0312-8 18038275 (Pubitemid 50005258)
8. SA Farr WA Banks K Uezu FS Gaskin JE Morley 2004 DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice Life Sci 75 2775 2785 10.1016/j.lfs.2004.05.026 1:CAS:528:DC%2BD2cXotFCmtbg%3D 15464829 (Pubitemid 39349264)
9. RE Hartman Y Izumi KR Bales SM Paul DF Wozniak DM Holtzman 2005 Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease J Neurosci 25 6213 6220 10.1523/JNEUROSCI.0664-05.2005 1:CAS:528: DC%2BD2MXmtFKntLg%3D 15987951 (Pubitemid 40923488)
10. C Hawkes 2006 Olfaction in neurodegenerative disorder Adv Otorhinolaryngol 63 133 151 16733338
11. A Hetényi L Fülöp TA Martinek E Wéber K Soós B Penke 2008 Ligand-induced flocculation of neurotoxic fibrillar Aβ(1-42) by noncovalent crosslinking Chembiochemistry 9 748 757 10.1002/cbic.200700351
12. S Horvát A Fehér H Wolburg P Sipos S Veszelka A Tóth L Kis A Kurunczi G Balogh L Kürti I Eros P Szabó- Révész MA Deli 2009 Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue Eur J Pharm Biopharm 72 252 259 10.1016/j.ejpb.2008.10.009 19007885
13. M Hrnkova N Zilka Z Minichova P Koson M Novak 2007 Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats Brain Res 1130 206 213 10.1016/j.brainres.2006.10.085 1:CAS:528:DC%2BD2sXls1ajtw%3D%3D 17169350 (Pubitemid 46053885)
14. C Iadecola 2003 Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia Cell Mol Neurobiol 23 681 689 10.1023/A:1025092617651 1:CAS:528:DC%2BD3sXmtVGrtro%3D 14514024 (Pubitemid 37071493)
15. L Illum 2000 Transport of drugs from the nasal cavity to the central nervous system Eur J Pharm Sci 11 1 18 10.1016/S0928-0987(00)00087-7 1:CAS:528:DC%2BD3cXksFektLo%3D 10913748 (Pubitemid 30410839)
16. L Illum 2004 Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56 3 17 10.1211/0022357022539 1:CAS:528:DC%2BD2cXhvVCks7Y%3D 14979996 (Pubitemid 38195323)
17. NC Inestrosa AE Reyes MA Chacón W Cerpa A Villalón J Montiel G Merabachvili R Aldunate F Bozinovic F Aboitiz 2005 Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu Neurobiol Aging 26 1023 1028 10.1016/j.neurobiolaging.2004.09.016 1:CAS:528:DC%2BD2MXhvVekt7w%3D 15748782 (Pubitemid 40312666)
18. G Juhász A Márki G Vass L Fülöp D Budai B Penke G Falkay V Szegedi 2009 An intraperitoneally administered pentapeptide protects against Abeta (1-42) induced neuronal excitation in vivo J Alzheimers Dis 16 189 196 19158435
19. HD Kim Y Cao FK Kong KR Van Kampen TL Lewis Z Ma DC Tang K Fukuchi 2005 Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF Vaccine 23 2977 2986 10.1016/j.vaccine.2004.12.015 1:CAS:528:DC%2BD2MXivV2iu7k%3D 15811643 (Pubitemid 40462436)
20. S Kraemer R Apfelbach 2004 Olfactory sensitivity, learning and cognition in young adult and aged male Wistar rats Physiol Behav 81 435 442 10.1016/j.physbeh.2004.01.012 1:CAS:528:DC%2BD2cXjvVagsbg%3D 15135015 (Pubitemid 38591532)
21. CA Lemere ET Spooner J LaFrancois B Malester C Mori JF Leverone Y Matsuoka JW Taylor RB DeMattos DM Holtzman JD Clements DJ Selkoe KE Duff 2003 Evidence for peripheral clearance of cerebral Abeta protein following chronic, active Abeta immunization in PSAPP mice Neurobiol Dis 14 10 18 10.1016/S0969-9961(03)00044-5 1:CAS:528:DC%2BD3sXnt1amtrc%3D 13678662 (Pubitemid 37103175)
22. S Nag F Tang 1998 Cholinergic lesions of the rat brain by ibotenic acid and 192 IgG-saporin: effects on somatostatin, substance P and neuropeptide Y levels in the cerebral cortex and the hippocampus Neurosci Lett 252 83 86 10.1016/S0304-3940(98)00545-X 1:CAS:528:DyaK1cXltleqtLc%3D 9756327 (Pubitemid 28384498)
23. A Nitta A Itoh T Hasegawa T Nabeshima 1994 Beta-amyloid protein-induced Alzheimer's disease animal model Neurosci Lett 170 63 66 10.1016/0304-3940(94) 90239-9 1:CAS:528:DyaK2cXkvVSisLY%3D 8086012
24. M Nivsarkar A Banerjee H Padh 2008 Cyclooxygenase inhibitors: a novel direction for Alzheimer's management Pharmacol Rep 60 692 698 1:CAS:528:DC%2BD1MXisFCgtLg%3D 19066416
25. WM Pardridge 2005 The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 3 14 10.1602/neurorx.2.1.3 15717053 (Pubitemid 40128022)
26. K Satoh S Shirabe K Eguchi A Yamauchi Y Kataoka M Niwa N Nishida S Katamine 2004 Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease Cell Mol Neurobiol 24 873 875 10.1007/s10571-004-6926-7 1:CAS:528:DC%2BD2MXjs1anuw%3D%3D 15672687 (Pubitemid 40174236)
27. TJ Seabrook JK Bloom M Iglesias ET Spooner DM Walsh CA Lemere 2004 Species-specific immune response to immunization with human versus rodent A beta peptide Neurobiol Aging 25 1141 1151 10.1016/j.neurobiolaging.2003.12.008 1:CAS:528:DC%2BD2cXmslequr8%3D 15312960 (Pubitemid 39094017)
28. E Sipos A Kurunczi A Kasza J Horváth K Felszeghy S Laroche J Toldi A Párducz B Penke Z Penke 2007 Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease Neuroscience 147 28 36 10.1016/j.neuroscience.2007.04.011 1:CAS:528: DC%2BD2sXmtlWhtb0%3D 17499931 (Pubitemid 46881105)
29. RG Thorne GJ Pronk V Padmanabhan WH Frey 2004 Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration Neuroscience 127 481 496 10.1016/j.neuroscience.2004.05.029 1:CAS:528:DC%2BD2cXlvVSqurg%3D 15262337 (Pubitemid 38950662)
30. H Wolburg K Wolburg-Buchholz H Sam S Horvát MA Deli AF Mack 2008 Epithelial and endothelial barriers in the olfactory region of the nasal cavity of the rat Histochem Cell Biol 130 127 140 10.1007/s00418-008-0410-2 1:CAS:528:DC%2BD1cXmtlWit7Y%3D 18340454
31. M Zarándi K Soós L Fülöp Z Bozsó Z Datki GK Tóth B Penke 2007 Synthesis of Abeta[1-42] and its derivatives with improved efficiency J Pept Sci 13 94 99 10.1002/psc.801 17103463 (Pubitemid 46290945)
32. N Zilka P Filipcik P Koson L Fialova R Skrabana M Zilkova G Rolkova E Kontsekova M Novak 2006 Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo FEBS Lett 580 3582 3588 10.1016/j.febslet.2006.05.029 1:CAS:528:DC%2BD28XmtVOmsbs%3D 16753151 (Pubitemid 43902790)
33. BV Zlokovic 2005 Neurovascular mechanisms of Alzheimer's neurodegeneration Trends Neurosci 28 202 208 10.1016/j.tins.2005.02.001 1:CAS:528:DC%2BD2MXivV2htrk%3D 15808355 (Pubitemid 40445527)